Status:
COMPLETED
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Heart Diseases
Eligibility:
All Genders
45+ years
Brief Summary
Coronary heart disease (CHD) is a serious health concern that affects millions of people in the United States. It is usually caused by atherosclerosis-a condition that occurs when fatty material and p...
Detailed Description
CHD is the leading cause of death in the United States. Preliminary research has shown that CHD is associated with oxidative and inflammatory changes in high-density lipoprotein (HDL) cholesterol, whi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Eligible for main AIM-HIGH study (NCT00120289)
- Willing to provide informed consent for participation in this substudy
Exclusion
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
324 Patients enrolled
Trial Details
Trial ID
NCT00880178
Start Date
May 1 2008
End Date
September 1 2011
Last Update
May 14 2018
Active Locations (29)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiovascular Associates
Birmingham, Alabama, United States, 35213
2
Cardiovascular Consultants
Phoenix, Arizona, United States, 85032
3
Long Beach VA Medical Center
Long Beach, California, United States, 90822
4
Christiana Care Health Services
Newark, Delaware, United States, 19718